Vericel Corp is a Milwaukee-based biopharmaceutical company that specializes in advanced cell therapy products for the sports medicine and severe burn care markets. They manufacture and market two cell therapy products in the United States and hold an exclusive license for the North American commercial rights to NexoBrid, a biological orphan product approved for eschar removal of severe thermal burns.
With a focus on innovative treatments, Vericel is known for its unique life-enhancing therapies that have garnered positive patient testimonials. The company is committed to advancing clinical development and has an extensive pipeline of clinical trials and scientific publications. Vericel also prioritizes corporate compliance and maintains a strong corporate governance structure. As a leader in the field, Vericel continues to make significant contributions to the medical community through its advanced therapies.
Generated from the website